Anxiety disorder induced by unknown or unspecified psychoactive substance (Q40516): Difference between revisions

@@ description / pt-br / description / pt-br @@
+Transtorno de ansiedade induzido por substância psicoativa desconhecida ou não especificada é caracterizado por sintomas ansiosos (p. ex., apreensão ou preocupação, medo, sintomas fisiológicos de ativação autonômica excessiva, comportamento de evitação) que se desenvolvem durante ou logo após intoxicação por ou abstinência de uma substância psicoativa desconhecida ou não especificada. Os sintomas não são mais bem explicados por um transtorno mental primário (p.ex., transtorno de ansiedade e relacionado ao medo, transtorno depressivo com sintomas ansiosos proeminentes), como pode ser o caso se os sintomas de ansiedade precederam o início do uso da substância psicoativa desconhecida ou não especificada, se os sintomas persistem por um período de tempo considerável após a cessação do uso da substância psicoativa desconhecida ou não especificada ou a abstinência de substância psicoativa desconhecida ou não especificada, ou se há outra evidência de um transtorno mental primário preexistente com sintomas ansiosos (p. ex., história de episódios anteriores não associados ao uso da substância psicoativa desconhecida ou não especificada).
@@ description / en / description / en @@
+Anxiety disorder induced by unknown or unspecified psychoactive substance is characterised by anxiety symptoms (e.g., apprehension or worry, fear, physiological symptoms of excessive autonomic arousal, avoidance behaviour) that develop during or soon after intoxication with or withdrawal from an unknown or unspecified psychoactive substance. The symptoms are not better explained by a primary mental disorder (e.g., an Anxiety and fear-related disorder, a Depressive disorder with prominent anxiety symptoms), as might be the case if the anxiety symptoms preceded the onset of the use of the unknown or unspecified psychoactive substance, if the symptoms persist for a substantial period of time after cessation of the use of the unknown or unspecified psychoactive substance or withdrawal from the unknown or unspecified psychoactive substance, or if there is other evidence of a pre-existing primary mental disorder with anxiety symptoms (e.g., a history of prior episodes not associated with the use of the unknown or unspecified psychoactive substance).
@@ Property / Canonical URI @@
+https://id.who.int/icd/entity/62314683
@@ Property / Canonical URI: https://id.who.int/icd/entity/62314683 / rank @@
+Normal rank
@@ Property / CURIE @@
+CID11:6C4G.71
@@ Property / CURIE: CID11:6C4G.71 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-6C4G.71
@@ Property / Canary Token: dki-india-6C4G.71 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank
@@ Property / Linked ICD 10 @@
+F19
@@ Property / Linked ICD 10: F19 / rank @@
+Normal rank

Latest revision as of 06:21, 13 August 2026

Anxiety disorder induced by unknown or unspecified psychoactive substance is characterised by anxiety symptoms (e.g., apprehension or worry, fear, physiological symptoms of excessive autonomic arousal, avoidance behaviour) that develop during or soon after intoxication with or withdrawal from an unknown or unspecified psychoactive substance. The symptoms are not better explained by a primary mental disorder (e.g., an Anxiety and fear-related disorder, a Depressive disorder with prominent anxiety symptoms), as might be the case if the anxiety symptoms preceded the onset of the use of the unknown or unspecified psychoactive substance, if the symptoms persist for a substantial period of time after cessation of the use of the unknown or unspecified psychoactive substance or withdrawal from the unknown or unspecified psychoactive substance, or if there is other evidence of a pre-existing primary mental disorder with anxiety symptoms (e.g., a history of prior episodes not associated with the use of the unknown or unspecified psychoactive substance).

Language	Label	Description	Also known as
default for all languages	6C4G.71
English	Anxiety disorder induced by unknown or unspecified psychoactive substance	Anxiety disorder induced by unknown or unspecified psychoactive substance is characterised by anxiety symptoms (e.g., apprehension or worry, fear, physiological symptoms of excessive autonomic arousal, avoidance behaviour) that develop during or soon after intoxication with or withdrawal from an unknown or unspecified psychoactive substance. The symptoms are not better explained by a primary mental disorder (e.g., an Anxiety and fear-related disorder, a Depressive disorder with prominent anxiety symptoms), as might be the case if the anxiety symptoms preceded the onset of the use of the unknown or unspecified psychoactive substance, if the symptoms persist for a substantial period of time after cessation of the use of the unknown or unspecified psychoactive substance or withdrawal from the unknown or unspecified psychoactive substance, or if there is other evidence of a pre-existing primary mental disorder with anxiety symptoms (e.g., a history of prior episodes not associated with the use of the unknown or unspecified psychoactive substance).